Subgroup analysis based on the taxane regimen (weekly paclitaxel, dose-dense paclitaxel, and docetaxel) showed that the PTX-treated patients exhibited numerically lower incidences of grade 2 or higher neuropathy compared to controls, but these differences did not reach statistical significance ( P > 0.05, Supplementary Table S2 ).
← all excerpts
Assessing the efficacy and safety of pentoxifylline in preventing chemotherapy-induced peripheral neuropathy and mucositis in breast cancer patients.
1
0.0500
0.0500